Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

The antidiabetic drug metformin has been proposed to affect non-alcoholic fatty liver disease (NAFLD) through its effects on intestinal microbiota and barrier function. However, so far most studies focused on long-term effects and more progressed disease stages. The aim of this study was to assess i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Brandt, Annette, Hernández-Arriaga, Angélica, Kehm, Richard, Sánchez, Victor, Jin, Cheng Jun, Nier, Anika, Baumann, Anja, Camarinha-Silva, Amélia, Bergheim, Ina
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491483/
https://ncbi.nlm.nih.gov/pubmed/31040374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-43228-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados